World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
66
Citations
16060
World Ranking
8646
National Ranking
3879

Pamela L. Zeitlin publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Pamela L. Zeitlin sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 178 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Pamela L. Zeitlin D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Pamela L. Zeitlin sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 66 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Pamela L. Zeitlin is affiliated with National Jewish Health in the United States. Their research primarily focuses on medicine, with a significant emphasis on pulmonary and respiratory medicine. Their work extends into related subfields, including physiology, immunology, plant science, and surgery.

The scientist's main topics of study include cystic fibrosis research advances, neonatal respiratory health research, asthma and respiratory diseases, tracheal and airway disorders, eosinophilic esophagitis, IL-33, ST2, and ILC pathways, and legume nitrogen-fixing symbiosis.

Pamela L. Zeitlin has contributed multiple papers that cover important aspects of respiratory function and diseases. Notable recent publications include:

  • Elexacaftor is a CFTR potentiator and acts synergistically with ivacaftor during acute and chronic treatment (2021, Scientific Reports)
  • IL-13-programmed airway tuft cells produce PGE2, which promotes CFTR-dependent mucociliary function (2022, JCI Insight)
  • A common polymorphism in the Intelectin-1 gene influences mucus plugging in severe asthma (2024, Nature Communications)
  • Effect of apical chloride concentration on the measurement of responses to CFTR modulation in airway epithelia cultured from nasal brushings (2020, Physiological Reports)
  • Receptor-mediated activation of CFTR via prostaglandin signaling pathways in the airway (2022, American Journal of Physiology-Lung Cellular and Molecular Physiology)

The frequent coauthors collaborating with Pamela L. Zeitlin include Preston E. Bratcher, Ciarán A. Shaughnessy, Sangya Yadav, Camille M. Moore, and Michael T. Montgomery. These collaborations have contributed to the scientist's research outputs, particularly in pulmonary and respiratory medicine.

Publication venues where Pamela L. Zeitlin has frequently contributed include:

  • Scientific Reports
  • Journal of Cystic Fibrosis
  • JCI Insight
  • Nature Communications
  • Physiological Reports

Their research topics span advanced studies on cystic fibrosis, respiratory health conditions from neonatal stages to asthma and airway disorders, and molecular pathways influencing respiratory epithelial function. The integration of these topics reflects a comprehensive engagement with medical and physiological aspects of respiratory disease mechanisms and therapies.

Best Publications

  • Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.

    Terence R. Flotte;Sandra A. Afione;Carol Conrad;Sharon A. McGrath

  • Biodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier.

    Benjamin C. Tang;Michelle Dawson;Michelle Dawson;Samuel K. Lai;Ying Ying Wang

  • Defective regulation of outwardly rectifying Cl− channels by protein kinase A corrected by insertion of CFTR

    Marie Egan;Terence Flotte;Terence Flotte;Sandra Afione;Rikki Solow

  • Immunocytochemical localization of the cystic fibrosis gene product CFTR.

    Isabelle Crawford;Peter C. Maloney;Pamela L. Zeitlin;William B. Guggino

  • A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: partial restoration of nasal epithelial CFTR function.

    Ronald C. Rubenstein;Pamela L. Zeitlin

  • In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR.

    Ronald C. Rubenstein;Marie E. Egan;Pamela L. Zeitlin

  • Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter

    Terence R. Flotte;Sandra A. Afione;Rikki Solow;Mitchell L. Drumm

  • A Cystic Fibrosis Bronchial Epithelial Cell Line: Immortalization by Adeno-12-SV40 Infection

    P. L. Zeitlin;L. Lu;J. Rhim;G. Cutting

  • Significant microbiological effect of inhaled tobramycin in young children with cystic fibrosis.

    Ronald L. Gibson;Julia Emerson;Sharon McNamara;Jane L. Burns

  • The penetration of fresh undiluted sputum expectorated by cystic fibrosis patients by non-adhesive polymer nanoparticles.

    Jung Soo Suk;Samuel K. Lai;Ying Ying Wang;Laura M. Ensign

  • Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of ΔF508-CFTR

    Ronald C. Rubenstein;Pamela L. Zeitlin

  • Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial.

    Richard B. Moss;David Rodman;L. Terry Spencer;Moira L. Aitken

  • Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial

    Eitan Kerem;Michael W Konstan;Kris De Boeck;Frank J Accurso

  • Phase I Trial of Intranasal and Endobronchial Administration of a Recombinant Adeno-Associated Virus Serotype 2 (rAAV2)-CFTR Vector in Adult Cystic Fibrosis Patients: A Two-Part Clinical Study

    Terence R. Flotte;Pamela L. Zeitlin;Thomas C. Reynolds;Alison E. Heald

  • Gene Expression from Adeno-associated Virus Vectors in Airway Epithelial Cells

    Terence R. Flotte;Rikki Solow;Roland A. Owens;Sandra Afione

  • Mutation in the gene responsible for cystic fibrosis and predisposition to chronic rhinosinusitis in the general population

    Xin Jing Wang;Birgitta Moylan;Donald A. Leopold;Jean Kim

  • Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration.

    Terence R. Flotte;Sandra A. Afione;Pamela L. Zeitlin

  • Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial.

    Richard B Moss;Carlos Milla;John Colombo;Frank Accurso

  • Cl- channels in CF: lack of activation by protein kinase C and cAMP-dependent protein kinase

    Tzyh Chang Hwang;Luo Lu;Pamela L. Zeitlin;Dieter C. Gruenert

  • Evidence of CFTR Function in Cystic Fibrosis after Systemic Administration of 4-Phenylbutyrate

    Pamela L. Zeitlin;Marie Diener-West;Ronald C. Rubenstein;Michael P. Boyle

Frequent Co-Authors

William B. Guggino
William B. Guggino Johns Hopkins University
Garry R. Cutting
Garry R. Cutting Johns Hopkins University School of Medicine
Terence R. Flotte
Terence R. Flotte University of Massachusetts Chan Medical School
Bonnie W. Ramsey
Bonnie W. Ramsey University of Washington
Harvey B. Pollard
Harvey B. Pollard Uniformed Services University of the Health Sciences
Richard B. Moss
Richard B. Moss Stanford University
Barrie J. Carter
Barrie J. Carter National Institutes of Health
Marie Diener-West
Marie Diener-West Johns Hopkins University
David M. Jacobowitz
David M. Jacobowitz National Institutes of Health
John P. Clancy
John P. Clancy Cystic Fibrosis Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Pamela L. Zeitlin

Trending Scientists

Recently Published Articles